PE20121472A1 - COMBINATION OF DRUGS WITH THEOBROMINE AND ITS USE IN THERAPY - Google Patents

COMBINATION OF DRUGS WITH THEOBROMINE AND ITS USE IN THERAPY

Info

Publication number
PE20121472A1
PE20121472A1 PE2012000650A PE2012000650A PE20121472A1 PE 20121472 A1 PE20121472 A1 PE 20121472A1 PE 2012000650 A PE2012000650 A PE 2012000650A PE 2012000650 A PE2012000650 A PE 2012000650A PE 20121472 A1 PE20121472 A1 PE 20121472A1
Authority
PE
Peru
Prior art keywords
combination
theobromine
drugs
therapy
propoxycphene
Prior art date
Application number
PE2012000650A
Other languages
Spanish (es)
Inventor
John Brew
Robin Mark Bannister
Original Assignee
Biocopea Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocopea Ltd filed Critical Biocopea Ltd
Publication of PE20121472A1 publication Critical patent/PE20121472A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

SE REFIERE A UNA COMBINACION FARMACEUTICA QUE COMPRENDE: (A) TEOBROMINA Y (B) UN OPIATO TAL COMO CODEINA, MORFINA, DIAMORFINA, TEBAINA, PAPAVERINA, NOSCAPINA, ORIPAVINA, FENTANILO, ALFENTANILO, PROPOXIFENO, OXICODONA, ENTRE OTROS. DICHA COMBINACION PRESENTA UN EFECTO ANTITUSIVO POTENTE Y MAYOR QUE LA SUMA DE LOS FARMACOS INDIVIDUALESREFERS TO A PHARMACEUTICAL COMBINATION THAT INCLUDES: (A) THEOBROMINE AND (B) AN OPIATE SUCH AS CODEINE, MORPHINE, DIAMORPHINE, THEBAINE, PAPAVERIN, NOSCAPINE, ORIPAVIN, FENTHANIL, ALPHENTHANIL, PROPOXYCPHENE, OTHRENE. SUCH COMBINATION PRESENTS A POWERFUL ANTITUSSIVE EFFECT AND GREATER THAN THE SUM OF INDIVIDUAL DRUGS

PE2012000650A 2009-11-13 2010-11-12 COMBINATION OF DRUGS WITH THEOBROMINE AND ITS USE IN THERAPY PE20121472A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0919893.8A GB0919893D0 (en) 2009-11-13 2009-11-13 Drug composition and its use in therapy

Publications (1)

Publication Number Publication Date
PE20121472A1 true PE20121472A1 (en) 2012-11-30

Family

ID=41509327

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2012000650A PE20121472A1 (en) 2009-11-13 2010-11-12 COMBINATION OF DRUGS WITH THEOBROMINE AND ITS USE IN THERAPY

Country Status (18)

Country Link
EP (1) EP2498776A1 (en)
JP (2) JP2013510842A (en)
CN (1) CN102740853B (en)
AU (1) AU2010317668C1 (en)
BR (1) BR112012011224A2 (en)
CA (1) CA2780704C (en)
CO (1) CO6551745A2 (en)
EC (2) ECSP12011893A (en)
GB (1) GB0919893D0 (en)
IL (1) IL219769A0 (en)
MX (1) MX2012005538A (en)
NZ (1) NZ599957A (en)
PE (1) PE20121472A1 (en)
RU (1) RU2587329C2 (en)
SG (1) SG10201407496SA (en)
UA (1) UA105940C2 (en)
WO (1) WO2011058374A1 (en)
ZA (1) ZA201204247B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9308211B2 (en) 2009-06-16 2016-04-12 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
GB0910375D0 (en) 2009-06-16 2009-07-29 Biocopea Ltd Drug composition and its use in therapy
US9314465B2 (en) 2009-06-16 2016-04-19 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
US10016437B2 (en) 2009-06-16 2018-07-10 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
GB201111485D0 (en) * 2011-07-05 2011-08-17 Biocopea Ltd Drug composition and its use in therapy

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3850568D1 (en) * 1987-10-08 1994-08-11 Andor Bilas FABRIC MIXTURE TO STABILIZE THE METABOLISM LOCATION.
BR9407414A (en) * 1993-09-07 1996-11-12 Procter & Gamble Compositions containing a non-steroidal propionic acid anti-inflammatory agent amino acid salt and at least one decongestant an expectorant an antihistamine and an antitussive
HUP9700654A2 (en) 1997-03-26 1999-09-28 Dezső Korbonits Antitussive compositions containing theobromine
US6608073B1 (en) * 1998-10-14 2003-08-19 New Millennium Pharmaceutical Research, Inc. Intranasal codeine for the rapid suppression of cough and rapid relief of pain
HUP9802716A3 (en) * 1998-11-25 2000-08-28 Chinoin Gyogyszer Es Vegyeszet Pharmaceutical composition of analgesic activity
US8080554B2 (en) * 2001-12-12 2011-12-20 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation
EP1603533B1 (en) * 2003-02-28 2009-04-15 YM Biosciences Inc. Opioid delivery system
CN1593451A (en) * 2003-09-12 2005-03-16 杨喜鸿 Externally applied medicine for promoting male erection
EP1844792A4 (en) * 2004-12-14 2008-05-21 Shionogi & Co Therapeutic agent for constipation
US20080003280A1 (en) * 2006-06-26 2008-01-03 Levine Brian M Combination cough treatment compounds and method of treating common coughs
KR20080009994A (en) * 2006-07-25 2008-01-30 안국약품 주식회사 Compositions for treating of cough

Also Published As

Publication number Publication date
GB0919893D0 (en) 2009-12-30
JP2013510842A (en) 2013-03-28
WO2011058374A1 (en) 2011-05-19
RU2587329C2 (en) 2016-06-20
UA105940C2 (en) 2014-07-10
JP2016041748A (en) 2016-03-31
EP2498776A1 (en) 2012-09-19
AU2010317668A1 (en) 2012-06-07
AU2010317668B2 (en) 2015-01-22
AU2010317668C1 (en) 2016-02-11
SG10201407496SA (en) 2015-02-27
ECSP12011893A (en) 2012-10-30
CA2780704C (en) 2018-07-17
ECSP12011892A (en) 2012-09-28
CA2780704A1 (en) 2011-05-19
BR112012011224A2 (en) 2017-03-01
NZ599957A (en) 2014-05-30
RU2012124063A (en) 2013-12-20
IL219769A0 (en) 2012-07-31
ZA201204247B (en) 2013-02-27
CO6551745A2 (en) 2012-10-31
CN102740853B (en) 2015-04-08
CN102740853A (en) 2012-10-17
MX2012005538A (en) 2012-09-28

Similar Documents

Publication Publication Date Title
MX2012007769A (en) Random sampling for geophysical acquisitions.
AU345939S (en) Electronic device
AU347998S (en) Electronic device
PE20121472A1 (en) COMBINATION OF DRUGS WITH THEOBROMINE AND ITS USE IN THERAPY
GT201200304A (en) PHARMACEUTICAL COMPOSITIONS THAT INCLUDE HYDROMORPHONE AND NALOXONE
GB201020616D0 (en) Device for imparting distance information
AU348564S (en) Tablet computer
CL2013000718A1 (en) An inclusion complex comprising a) a cyclodextrin, b) fulvestrant and c) a carrier; its method of preparation; formulation and dosage form comprising the complex; preparation comprising the complex or formulation; and its use in the treatment of cancer and systemic lupus erythematosus, among other diseases.
AU349050S (en) Telephone
MX343598B (en) Theobromine in combination with an expectorant or a mucolytic for use in therapy.
GB2535954A (en) A support structure
UA108993C2 (en) MEDICINAL COMBINATION WITH THEOBROMINE AND ITS APPLICATION IN Cough
USD736784S1 (en) Portable electronic device with a graphical user interface
CO6541630A2 (en) THEOBROMINE COMBINATION WITH A DESCONGESTIVO AND ITS USE FOR THE TOS TREATMENT
USD736221S1 (en) Portable electronic device with a graphical user interface
MX2016016667A (en) Methods of treating cancer and preventing cancer drug resistance.
USD734765S1 (en) Portable electronic device with a graphical user interface
UA89010C2 (en) Combined analgesic and spasmolytic drug containing ketorolac and drotaverin
AU335160S (en) Speaker
AU337509S (en) Key holder
Wei Sustainable and Sound Development
Imanaliev An Advancing Alliance
CA143686S (en) Buccal medication delivery device adapter
Press Make Your Way Around China With Simple Chinese
UA57852U (en) Method for treating recurrent forms of allergodermatosis in patients with secondary immunodeficiency

Legal Events

Date Code Title Description
FC Refusal